Diseases, Conditions, Syndromes

Vaccine candidate for gonorrhea shows preclinical effectiveness

A report in the journal mBio, published by the American Society for Microbiology, describes a prototype vaccine candidate for Neisseria gonorrhoeae, the bacterium that causes gonorrhea, a sexually transmitted infection that ...

Medications

Global phase 3 trial of zoliflodacin

The Global Antibiotic Research and Development Partnership (GARDP), a not for profit organisation developing new treatments for drug resistant infections, and Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical ...

Diseases, Conditions, Syndromes

Nurse intervention using tech may improve PID care in youth

Adolescent and young adult women with pelvic inflammatory disease (PID) are more likely to experience decreases in Neisseria gonorrhoeae and Chlamydia trachomatis positivity with a technology-enhanced community health nursing ...

Diseases, Conditions, Syndromes

Gonorrhoea cases on the rise across Europe

Following a decline in notification rates in 2016, the number of gonorrhoea cases has gone up by 17% across the reporting EU/EEA countries with more than 89 000 confirmed diagnoses in 2017—more than 240 cases a day.

page 1 from 6

Gonorrhea

Gonorrhea (also colloquially known as the clap) is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. The usual symptoms in men are burning with urination and penile discharge. Women, on the other hand, are asymptomatic half the time or have vaginal discharge and pelvic pain. In both men and women if gonorrhea is left untreated, it may spread locally causing epididymitis or pelvic inflammatory disease or throughout the body, affecting joints and heart valves.

Treatment is commonly with ceftriaxone as antibiotic resistance has developed to many previously used medications.

In 2011, there were reports of some strains of gonorrhea showing resistance to ceftriaxone.

This text uses material from Wikipedia, licensed under CC BY-SA